Justia Blawg Search - Law Blogs, Lawyer Blogs, Legal Blogs Directory & Search Engine

Judge Stark excludes testimony of plaintiffs’ legal expert and excludes testimony of plaintiffs’ technical expert, in part

29 Nov 2012, 5:21 am by Pilar G. Kraman

AstraZeneca UK Limited v. [read post]

Delaware IP Law Blog - http://www.delawareiplaw.com/

The Varieties of Co-Religionist Commerce III

28 Nov 2012, 1:50 pm by Michael Helfand

I've recently attempted to present another alternative, which argues that the authority of religious institutions is derived from, to use the terminology of the Supreme Court in Watson v. [read post]

PrawfsBlawg - http://prawfsblawg.blogs.com/prawfsblawg/

Trade Secret | Noncompete – Issues and Cases in the News – October-November 2012

26 Nov 2012, 2:38 am by Russell Beck

Watson (D. [read post]

Fair Competition Law Blog - http://faircompetitionlaw.com

Wells v. Ortho Pharmaceutical Corp. Reconsidered – Part 1

12 Nov 2012, 4:14 pm by Schachtman

Emory University Hospital, 611 F.2d 604, 608 n. 13 (5th Cir.1980); Watson v. [read post]

Tortini - http://schachtmanlaw.com/blog/

What Was the Relator Thinking? Court Sanctions Relator and Counsel for Frivolous Qui Tam Claim

31 Oct 2012, 7:09 pm by A. Brian Albritton

USA ex rel Watson v. [read post]

False Claims Act & Qui Tam Law - http://falseclaimsactlaw.blogspot.com/

Qui Tam Off-label Trick or Treat

31 Oct 2012, 5:00 am by Steve McConnell

Watson v. [read post]

Drug and Device Law - http://druganddevicelaw.blogspot.com/

More on Graves v. CAS Medical Systems, Inc.

30 Oct 2012, 8:41 am by Brian A. Comer

This is contrary to the impression given by the appellate courts in Watson v. [read post]

South Carolina Products Liability Law Blog - http://scproductsliabilitylaw.blogspot.com/

Court Orders ANDA Approval in Pre-MMA 180-Day Exclusivity Case; Decision Appears to Have Post-MMA Implications

29 Oct 2012, 12:18 pm by FDABlog HPM

§ 314.94(a)(12)(v), “if the [ANDA] is for a drug or method of using a drug claimed by a patent and the applicant has a licensing agreement with the patent owner,” the application must contain a Paragraph IV certification as to that patent “and a statement that it has been granted a patent license. [read post]

FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/

Pay-For-Delay Enforcement Heats Up in the Wake of In re K-Dur Antitrust Litigation

23 Oct 2012, 6:30 am by Matthew Gilpin

Watson Pharmaceuticals, Inc., No. 12-416 (U.S. [read post]

The Brand Protection Blog - http://fulbrightbrandprotection.blogspot.com/

Motion to delay disciplinary action pending the outcome of a criminal investigation denied

12 Sep 2012, 10:13 am

Here the Appellate Division said that an employee was not entitled to a stay of the disciplinary case as a criminal defendant does not have a right to stay a related disciplinary proceeding pending the outcome of trial, citing Watson v City of Jamestown, 27 AD3d 1183. [read post]

New York Public Personnel Law - http://publicpersonnellaw.blogspot.com/

Plaintiffs’ Bar Tries to Run the Option on Res Ipsa Loquitur; Sacked by Supreme Court

10 Sep 2012, 4:30 am by Steven Buckingham

App. 1991), and more recently, in Watson v. [read post]

Abnormal Use: An Unreasonably Dangerous Products Liability Blog - http://www.abnormaluse.com/

The Egilman Chronicles

6 Sep 2012, 11:29 am by Bexis

Well, the first case on the list is Watson v. [read post]

Drug and Device Law - http://druganddevicelaw.blogspot.com/

Will the Supreme Court Weigh in on Reverse Payments in ANDA Cases?

4 Sep 2012, 7:04 am by Todd M. Nosher

Watson Pharmaceuticals, Inc., No. 10-12729 (11th Cir. [read post]